ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 85 filers reported holding ACELRX PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.25 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $255,000 | +381.1% | 118,675 | +600.9% | 0.01% | +600.0% |
| Q1 2017 | $53,000 | -50.5% | 16,933 | -38.6% | 0.00% | -66.7% |
| Q3 2016 | $107,000 | +87.7% | 27,580 | +29.3% | 0.00% | +200.0% |
| Q2 2016 | $57,000 | -66.1% | 21,337 | -61.0% | 0.00% | -80.0% |
| Q1 2016 | $168,000 | +21.7% | 54,707 | +52.4% | 0.01% | +150.0% |
| Q4 2015 | $138,000 | +213.6% | 35,904 | +148.2% | 0.00% | +100.0% |
| Q3 2015 | $44,000 | -21.4% | 14,463 | +9.2% | 0.00% | 0.0% |
| Q2 2015 | $56,000 | +19.1% | 13,244 | +9.2% | 0.00% | 0.0% |
| Q1 2015 | $47,000 | -53.0% | 12,125 | -18.4% | 0.00% | -50.0% |
| Q4 2014 | $100,000 | -26.5% | 14,856 | +17.7% | 0.00% | 0.0% |
| Q3 2013 | $136,000 | – | 12,626 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Values First Advisors, Inc. | 250,110 | $528,000 | 0.51% |
| XTX MARKETS LLC | 12,925 | $27,000 | 0.19% |
| Cornerstone Capital, Inc. | 491,560 | $1,037,000 | 0.15% |
| Aristides Capital LLC | 64,482 | $136,000 | 0.10% |
| LINCOLN CAPITAL CORP | 57,000 | $120,000 | 0.09% |
| HighVista Strategies LLC | 41,400 | $87,000 | 0.07% |
| Ahrens Investment Partners LLC | 61,500 | $130,000 | 0.05% |
| J Arnold Wealth Management Co | 18,000 | $38,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 114,437 | $241,000 | 0.03% |
| Avidian Wealth Solutions, LLC | 63,000 | $133,000 | 0.02% |